McLean Hospital 115 Mill Street Belmont, MA 02478
If you or a loved one are struggling with substance abuse, including the misuse of alcohol, prescription drugs, heroin, cocaine, marijuana, or opioids such as Oxycontin or Percocet, the Alcohol and Drug Abuse Inpatient Program addresses a wide range of diagnoses, provides individualized treatment, and identifies support and resources for you and your family.
Our expert staff is ready to help you. For more information or to make a referral, please call 844.222.6037.
For more than 40 years, the Alcohol and Drug Abuse Inpatient Program has been providing care for patients with substance use disorders with and without other co-occurring psychiatric conditions such as major depression, anxiety disorders, bipolar disorder, and post-traumatic stress disorder. Located in Proctor House on McLean’s Belmont campus, the program offers a safe and secure environment that is conducive to helping patients focus on addiction treatment and recovery.
Our team of highly trained clinicians and support staff specialize in treatment for drug and alcohol abuse and related mental health disorders and are devoted to improving the quality of life of patients and their families. Our 24-hour care also includes available emergency psychiatric and medical personnel.
Covered by most health insurance providers, our program is appropriate for individuals ages 18 and older who are living with addiction. Our short-term care is ideal for patients focusing on stabilization, detoxification, and recovery. The average length of stay for the inpatient program is 3-5 days.
We work in conjunction with a broad range of programs across the Division of Alcohol and Drug Abuse in order to provide comprehensive substance abuse treatment for patients at every level of care, from intensive inpatient detoxification to individual and group outpatient therapy offered by McLean’s Adult Outpatient Services. The division’s most popular programs are our residential Signature Recovery Programs: Fernside and Borden Cottage. A restored historic inn, the Fernside program is located near Wachusett Mountain in scenic Princeton, Massachusetts. Borden Cottage, located in Camden, Maine, offers discreet care in a setting that offers a 270° view of Penobscot Bay. Each self-pay location is beautifully furnished throughout and all rooms are private and include full baths.
Upon admission to the Alcohol and Drug Abuse Inpatient Program, we create an individualized treatment plan for each patient. This may incorporate a combination of group, family, and individual therapy targeted at medical stabilization, reducing the severity of the patient’s symptoms, and providing tools, ongoing support, and resources to prevent relapse. Designed to engage patients in their treatment, each day is carefully planned according to the individual’s needs with ample time for self-focus and group work.
Family involvement in treatment is strongly recommended, and with the permission of the patient, family members can be involved in assessment, care, and aftercare planning. Support and education is also offered, including a family support group in Proctor House every Monday evening for families of McLean Hospital patients.
Prescription drugs are the third most commonly abused category of drugs, behind alcohol and marijuana and ahead of cocaine, heroin, and methamphetamine. Overall, an estimated 48 million people have abused prescription drugs, representing nearly 20 percent of the US population.
In Massachusetts, opioid overdose is now the leading cause of injury death. In an effort to save lives, the Massachusetts Department of Public Health has created a program to promote the education of misusers of opioids and their families about the use of naloxone (also known as Narcan). During an opioid overdose, breathing can slow to the point of death. After being sprayed into the nose, Naloxone blocks the opioid and restores normal breathing. It is safe, easy to administer, and has no potential for abuse.
In a recent post on McLean’s blog, Hilary S. Connery, MD, PhD, urges us to reassess how we think about substance overdose deaths in general, to include greater focus on self-harm prevention and education efforts for prescribers, patients, families, and community stakeholders.